MEDICINE DETAILS
Xalkori
Active ingredient: Crizotinib
Neutral reference profile for an independent medicine-access consultancy enquiry about Xalkori (Crizotinib). No medicine is offered for sale.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Xalkori used for?
Xalkori (Crizotinib) is a prescription cancer medication used to treat non-small cell lung cancer (NSCLC). It is specifically prescribed for patients with ALK-positive or ROS1-positive NSCLC, where it helps slow down tumor growth.
NSCLC is one of the most common types of lung cancer, and genetic mutations can cause uncontrolled cell growth. Xalkori is a targeted therapy designed for patients with ALK or ROS1 mutations.
Xalkori belongs to the protein kinase inhibitor class and works by blocking the ALK and ROS1 enzymes, preventing cancer cells from growing and spreading. It is taken orally in capsule form and is recommended for patients with advanced-stage NSCLC. Regular use can slow tumor progression, reduce symptoms, and extend survival.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Xalkori identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
20 mg · 60 capsules Catalogue organisation: Pfizer Pharma GmbH
-
50 mg · 60 capsules Catalogue organisation: Pfizer Pharma GmbH
-
150 mg · 60 capsules Catalogue organisation: Pfizer Pharma GmbH
-
200 mg · 60 capsules Catalogue organisation: Pfizer Pharma GmbH
-
250 mg hard capsules · 60 capsules Catalogue organisation: CC Pharma GmbH
OFFICIAL SOURCES
Check the Xalkori record at an official source.
Search for “Xalkori” or “Crizotinib”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Xalkori.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Xalkori
01What is Xalkori?＋
This directory record associates the brand name Xalkori with the active ingredient Crizotinib. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Xalkori strengths and packs are recorded?＋
The catalogue currently shows: 20 mg · 60 capsules; 50 mg · 60 capsules; 150 mg · 60 capsules; 200 mg · 60 capsules. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Xalkori?＋
Catalogue records currently name: Pfizer Pharma GmbH, CC Pharma GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Xalkori?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Xalkori, payment request, stock guarantee or binding offer.
06Can I buy Xalkori from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.